enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Low-intensity pulsed ultrasound - Wikipedia

   en.wikipedia.org/.../Low-intensity_pulsed_ultrasound

   Low intensity pulsed ultrasound has been proposed as a therapy to support bone healing after fractures, [1] osteomies, or delayed healing. A 2017 review, however, found no trustworthy evidence for the use of low intensity pulsed ultrasound for bone healing, mostly based on the large pragmatic randomized controlled trial published in 2016.

3. Oncotripsy - Wikipedia

   en.wikipedia.org/wiki/Oncotripsy

   A low intensity (ISPTA < 5 W/cm2) pulsed ultrasound (LIPSA) approach can exploit the mechanical properties of neoplastic cells to target them for destruction. Ultrasound applied at a frequency of 0.5–0.67 MHz for >20 ms causes selective disruption of a panel of breast, colon, and leukemia cancer cell models in suspension without significantly damaging healthy immune or red blood cells.

4. Sonodynamic therapy - Wikipedia

   en.wikipedia.org/wiki/Sonodynamic_therapy

   The mechanism of action for sonodynamic therapy is the use of low-intensity ultrasound through the use of focused mechanical waves to create a cytotoxic effect. However, SDT itself is non-thermal, non-toxic, and is able to non-invasively penetrate deep into tissue compared to other delivery methods such as photodynamic therapy.

5. Therapeutic ultrasound - Wikipedia

   en.wikipedia.org/wiki/Therapeutic_ultrasound

   Other uses of ultrasound for therapeutic benefit are at various stages in transitioning from research to clinical use and include: high-intensity focused ultrasound (HIFU), targeted ultrasound drug delivery, trans-dermal ultrasound drug delivery, ultrasound hemostasis, cancer therapy, and ultrasound assisted thrombolysis [2] [3] Ultrasound used ...

6. Focused ultrasound - Wikipedia

   en.wikipedia.org/wiki/Focused_ultrasound

   Studies on localized prostate cancer showed that, after treatment, progression-free survival rates were high for low- and intermediate- risk patients with recurrent prostate cancer. [3] The InsighTec ExAblate 2000 was the first MRgFUS system to obtain FDA market approval, [4] US patent 5,247,935.

7. Lower urinary tract symptoms - Wikipedia

   en.wikipedia.org/wiki/Lower_urinary_tract_symptoms

   The International Prostate Symptom Score (IPSS) can be used to gauge the symptoms, along with physician examination. Other primary and secondary tests are often carried out, such as a PSA (Prostate-specific antigen) test, [17] urinalysis, ultrasound, urinary flow studies, imaging, temporary prostatic stent placement, prostate biopsy and/or ...